- Home
- CLRB vs COSM Comparison
CLRB vs COSM Comparison
Compare CLRB & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- COSM
- Stock Information
- Founded
- CLRB 2002
- COSM 2009
- Country
- CLRB United States
- COSM United States
- Employees
- CLRB N/A
- COSM N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- COSM Other Pharmaceuticals
- Sector
- CLRB Health Care
- COSM Health Care
- Exchange
- CLRB Nasdaq
- COSM Nasdaq
- Market Cap
- CLRB 14.2M
- COSM 12.3M
- IPO Year
- CLRB N/A
- COSM 2013
- Fundamental
- Price
- CLRB $5.49
- COSM $0.93
- Analyst Decision
- CLRB Hold
- COSM
- Analyst Count
- CLRB 2
- COSM 0
- Target Price
- CLRB N/A
- COSM N/A
- AVG Volume (30 Days)
- CLRB 89.6K
- COSM 479.1K
- Earning Date
- CLRB 11-17-2025
- COSM 11-13-2025
- Dividend Yield
- CLRB N/A
- COSM N/A
- EPS Growth
- CLRB N/A
- COSM N/A
- EPS
- CLRB N/A
- COSM N/A
- Revenue
- CLRB N/A
- COSM $55,093,442.00
- Revenue This Year
- CLRB N/A
- COSM $28.14
- Revenue Next Year
- CLRB N/A
- COSM N/A
- P/E Ratio
- CLRB N/A
- COSM N/A
- Revenue Growth
- CLRB N/A
- COSM N/A
- 52 Week Low
- CLRB $4.11
- COSM $0.28
- 52 Week High
- CLRB $67.50
- COSM $1.28
- Technical
- Relative Strength Index (RSI)
- CLRB 60.03
- COSM 60.41
- Support Level
- CLRB $5.05
- COSM $0.86
- Resistance Level
- CLRB $5.34
- COSM $1.07
- Average True Range (ATR)
- CLRB 0.34
- COSM 0.10
- MACD
- CLRB 0.07
- COSM 0.02
- Stochastic Oscillator
- CLRB 98.15
- COSM 73.76
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.